That gives me 13 May plus the end of study evaluat
Post# of 72440
Even though it's blind we should get somewhat of a bone at the half way point which imo, has just passed last week. Because it's so many sites, it may take a bit to get a full read so I think we need to be patient.
From the 10Q
The Company expects interim analysis top-line results in the second quarter of calendar 2017
December 19, 2016
Cellceutix Reports 24 Core Phase 2b Clinical Trial Sites for Oral Prurisol Treatment of Moderate-To-Severe Psoriasis Initiated and Open for Screening
Prurisol
www.cellceutix.com/press-release/2016/12/19/cellceutix-reports-24-core-phase-2b-clinical-trial-sites-for-oral-prurisol-treatment-of-moderate-to-severe-psoriasis-initiated-and-open-for-screening
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
https://clinicaltrials.gov/ct2/show/NCT029493...amp;rank=5
Quote:
Posted By: BooDog
Re: Chemdeps #32227
I think you're missing the screening 4 weeks and follow up 4 weeks.
https://clinicaltrials.gov/ct2/show/NCT029493...amp;rank=5
Quote:
Posted By: Chemdeps
Someone tell me if my math is correct....December 19th is when the P trial started (per CTIX PR issued that day)....84 days is the trial duration and that should have been March 13th (Monday). Compilation of results from the early participants should be ramping up, correct?
Read More: http://investorshangout.com/post/view?id=4417...z4bU8ezUVu